Pfizer Vaccines launches first Centre of Excellence
The University of Louisville has been named as Pfizer’s first ‘Centre of Excellence’, part of its Vaccine Division’s global programme of collaborations with academic...
Lilly launching two new lower-priced insulins
Eli Lilly is introducing two lower-price insulins in the US following earlier efforts and encouragement from policymakers.
Its new lower-priced insulins will have 50% lower...
First commercial launch for blubird’s one-time gene therapy Zynteglo
bluebird bio has made Zynteglo commercially available for the first time after the one-time gene therapy was launched in Germany.
The therapy is intended for...
Herceptin biosimilar launched in US
A biosimilar of cancer drug Herceptin (trastuzumab) has been launched in the US by Mylan and Biocon.
Ogivri (trastuzumab-dkst) was the first biosimilar trastuzumab approved...
Neuraxpharm grows European presence with Portugal expansions
Specialty pharmaceutical company, Neuraxpharm, is expanding its operations in Southern Europe with the launch of Neuraxpharm Portugal.
Based in Lisbon, Neuraxpharm Portugal will be part...
